Related Experiment Videos
[Individual silicon applicator for nasopharyngeal brachytherapy]
1Klinik und Poliklinik für HNO-Heilkunde, Universitätskliniken des Saarlandes. bernhard.schick@uniklinik-saarland.de
Laryngo- Rhino- Otologie
|August 19, 2004
Summary
A novel individual silicon applicator enables safe and effective intracavitary brachytherapy for nasopharyngeal cancer. This method achieved tumor control in all treated patients, improving head and neck cancer therapy.
Area of Science:
- Oncology
- Medical Physics
- Biomaterials
Context:
- Head and neck cancers, including nasopharyngeal cancer, often require advanced treatment modalities beyond conventional surgery, radiation, and chemotherapy.
- Brachytherapy, particularly intracavitary brachytherapy, offers a valuable treatment option for primary, residual, or recurrent head and neck malignancies.
- Nasopharyngeal cancer is a well-suited indication for intracavitary brachytherapy, which can be delivered using commercial or custom-made applicators.
Purpose:
- To present the technique for manufacturing a custom individual nasopharyngeal silicon applicator.
- To report the clinical experience with this applicator in three patients undergoing brachytherapy for nasopharyngeal cancer or lymphoma.
- To evaluate the safety and efficacy of the custom applicator in delivering high-dose-rate brachytherapy.
Summary:
- An individual nasopharyngeal silicon applicator was manufactured using shore 12 silicon after imprinting and plaster casting under general anesthesia.
- The applicator, featuring two integrated tubes, facilitated safe endocavitary brachytherapy utilizing the high-dose-rate afterloading method.
- Successful tumor control was achieved in all three patients treated with this custom applicator.
Impact:
- The developed individual silicon applicator is suitable for intracavitary brachytherapy of the nasopharynx.
- This custom applicator represents a valuable addition to the primary treatment of nasopharyngeal cancer.
- The technique offers a potentially improved method for targeted radiation delivery in nasopharyngeal malignancies.